Rule 170 of the Drugs and Cosmetics Rules
On 27th August, 2024, the Supreme Court of India, while hearing the case against Patanjali Ayurved, pulled up the AYUSH Ministry for its July 1, 2024, notification asking state licensing authorities “not to initiate/take any action under” Rule 170 of the Drugs and Cosmetics Act, 1940.
What is Rule 170?
- Introduction Date: It was introduced in 2018 to govern the manufacture, storage, and sale of medicines in the country, “specifically for controlling inappropriate advertisements of Ayurvedic, Siddha and Unani medicines”.
- Rationale: The rule was introduced after a parliamentary standing committee highlighted the problem of misleading claims, and the need for the ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
India Watch
- 1 Impact Assessment Studies on Smart Cities Mission
- 2 Viksit Panchayat Karmayogi Initiative
- 3 Parliamentary Committee Raises Concerns over MGNREGA
- 4 CBIC’s Citizen-centric Initiative for Taxpayers
- 5 Amendment to the Conduct of Election Rules
- 6 SC Directions on Conservation of Scared Groves
- 7 Supreme Court Expands NIA’s Powers
- 8 SC Judgment on Temporary Employment in Government Institutions
- 9 SC on Misuse of Section 498A of IPC
- 10 ‘Anna Chakra’: Optimizing PDS Supply chain
